Sesame Care operates a cash-pay clinician marketplace where weight-loss program fees and medication costs vary by location and provider. No standardized membership fee or all-in medication price is published, making upfront cost comparison difficult.

Zealthy advertises compounded semaglutide from $151 per month when paying quarterly upfront, but the total quarterly charge, membership fees, and month-to-month cash rate remain undisclosed on public pages.

Alan Meds advertises bundled pricing but official pages show conflicting semaglutide structures. We document advertised rates, recurring-cost uncertainty, and included services as of September 2026.

Trava does not publish dose-specific GLP-1 pricing. No verified evidence shows whether monthly rates change during dose escalation or remain flat across all doses.

Mochi Health advertises $60 semaglutide or $90 tirzepatide plus a first-month membership rate, but three key costs remain undisclosed: ongoing membership rates, medication prices at escalated doses, and any visit, lab, or shipping fees.

Sesame Care operates as a clinician marketplace and does not publish stable GLP-1 medication pricing. Here's what that means for long-term treatment budgets and how transparent alternatives compare.

Form Health charges $299/month for physician and dietitian access, but that rate excludes medication and lab costs—the two largest expenses in weight-loss treatment. We break down the fee structure and compare it with all-inclusive alternatives.

Pomegranate Health advertises $119/month semaglutide and $149/month tirzepatide with "dose tiers in app," but the provider does not publish per-tier pricing on its website. We document what the evidence shows, where it stops, and how PlexusDx's same-price-at-every-dose model compares.

Found's published rates bundle compounded medication and care, but the every-4-weeks billing cycle, insurance copays, and unstated lab and shipping fees create cost uncertainty. This breakdown shows what's included, what's separate, and how the annual math compares to transparent alternatives.

Alan Meds does not publish tirzepatide pricing on its website; the total appears only after intake completion. We document what the evidence shows, compare compounded tirzepatide costs where data exists, and explain when transparent pricing matters.

Hims & Hers advertises compounded semaglutide at $199/month (six-month prepaid per-month rate), but the company does not publicly disclose whether that rate applies to all doses or changes when your provider increases your prescription strength.

Trava does not publish pricing, cancellation terms, or medication details online. This article explains what verified evidence exists, where gaps remain, and how to plan a switch when one provider operates behind an intake gate.

Zealthy advertises compounded semaglutide from $151 per month on a quarterly prepaid plan, but checkout totals and membership fees are not disclosed on its public pages. PlexusDx offers transparent month-to-month and prepaid pricing with no membership fee.